_____________________________________________________________________
LEAD Action News Volume 22 Number 4 December 2024 Page 59 of 131
Clinical and population strategies to protect children
from low-level lead poisoning - by Prof Bruce
Lanphear
LEAPP Alliance
Email from Professor Bruce Lanphear, Faculty of Health Sciences, Simon Fraser University,
Vancouver, British Columbia, Canada and LEAPP Alliance - Lead Exposure and Poisoning Prevention
Alliance - A joint initiative of the Lead Containing Materials Association and Lead Safe World UK, December
2024
From: Bruce Lanphear
Sent: Tuesday, 31 December 2024 2:56 AM
Subject: Re: LEAPP Alliance Update
Tim and others:
Re: article by Laura Hughes in the Financial Times: 'A timebomb’: fears for children being
poisoned by lead paint in UK homes - Lack of routine testing means thousands of youngsters
could be suffering from effects, say experts.
It is encouraging to read high-profile articles like Laura's.
I encourage LEAPP Alliance to have in-depth discussion on clinical and
population strategies to protect children from low-level lead poisoning. The US
led population strategies in the 1970s and 1980s, but then shifted to clinical
strategies. These two strategies are complementary, but for the past 30 years
the US emphasized the clinical strategy (testing children in the clinic setting) at
the expense of a population strategy.
The clinical strategy is important, but if sufficient investments are made in
population strategies (e.g., replacing lead service lines, identifying residential
lead hazards, banning leaded aviation fuel, and so on), then clinical strategies
will become unnecessary over the next 10 years.
Some of the key strategies to discuss are: